The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Greenstein Leonard M. since 2013.
This trader's CIK number is 1519692.
At the time of last reporting, Greenstein Leonard M. was the Chief Financial Officer of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS).
Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | ELGX | 0 | $0 | 1,253 | $17,554 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | TARS | 0 | $0 | 21,966 | $310,876 | 4,462 | $0 |
2022 | TARS | 0 | $0 | 10,000 | $164,000 | 0 | $0 |
2. Tarsus Pharmaceuticals, Inc. (TARS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-05-28 | ELGX | Sale | 1,253 | 14.01 | 17,554 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-04-20 | TARS | Sale | 5,000 | 14.02 | 70,100 |
2023-03-21 | TARS | Sale | 326 | 12.89 | 4,202 |
2023-03-22 | TARS | Sale | 332 | 12.64 | 4,196 |
2023-03-23 | TARS | Sale | 346 | 12.15 | 4,203 |
2023-03-17 | TARS | Sale | 316 | 13.28 | 4,196 |
2023-03-20 | TARS | Sale | 333 | 12.61 | 4,199 |
2023-03-16 | TARS | Sale | 5,313 | 13.44 | 71,380 |
2023-03-15 | TARS | Option Ex | 4,462 | .00 | 0 |
2023-02-16 | TARS | Sale | 5,000 | 15.12 | 75,600 |
2023-01-19 | TARS | Sale | 5,000 | 14.56 | 72,800 |
2022-11-17 | TARS | Sale | 5,000 | 16.54 | 82,700 |
2022-10-20 | TARS | Sale | 5,000 | 16.26 | 81,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenstein Leonard M. (Chief Financial Officer of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.